IMS: Q3 2025 saw 20% revenue growth, improved margins, and record international orders

About this update from Invent Medic Sweden Ab

Revenue grew over 20% year-over-year in Q3 2025, with improved profitability and strong international expansion, including record orders and new distribution agreements. Gross margin reached 79%, and the equity ratio improved to 63%.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Invent Medic Sweden Ab